References
Celprogen, Inc. (2018). Rat Embryonic Mesencephalic Dopaminergic Neuron Frozen Vial. https://www.celprogen.com/details.php?pid=10185
Cho, K. H., Kim, T. H., Kwon, S., Jung, W. S., Moon, S. K., Ko, C. N., Cho, S. Y., Jeon, C. Y., Lee, S. H., Choi, T. Y., Jun, J. H., Choi, J., Lee, M. S., & Chung, E. K. (2018, October 15). Complementary and Alternative Medicine for Idiopathic Parkinson’s Disease: An Evidence-Based Clinical Practice Guideline. Frontiers in Aging Neuroscience, 10(323), 323-331. https://doi.org/10.3389/fnagi.2018.00323
Kim, T. H., Cho, K. H., Jung, W. S., & Lee, M. S. (2012). Herbal medicines for Parkinson’s disease: a systematic review of randomized controlled trials. PloS One, 7(5), e35695. https://doi.org/10.1371/journal.pone.0035695
Leal, M. C., Casabona, J. C., Puntel, M., & Pitossi, F. J. (2013). Interleukin-1? and tumor necrosis factor-?: reliable targets for protective therapies in Parkinson’s Disease?. Frontiers in Cellular Neuroscience, 7(53). https://doi.org/10.3389/fncel.2013.00053
Mayo Clinic. (2018). Parkinson’s Disease. https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/
Ok, S. and Jeong, W. (2012). Optimization of Extraction Conditions for the 6-Shogaol-rich Extract from Ginger (Zingiber officinale Roscoe). Preventive Nutrition and Food Science, 17(2), 166-171. https://doi.org/10.3746/pnf.2012.17.2.166
Park, G., Kim, H. G., Ju, M. S., Ha, S. K., Park, Y., & Oh, M. S. (2013). 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson’s disease models via anti-neuroinflammation. Acta Pharmacologica Sinica, 34, 1131-1139. https://doi.org/10.1038/aps.2013.57
Parkinson’s Foundation. (2018). Over the Counter & Complementary Therapies. https://www.parkinson.org/Understanding-Parkinsons/Treatment/Over-the-Counter-and-Complementary-Therapies
Science Direct. (2018). Gingerol. Science Direct. https://www.sciencedirect.com/topics/neuroscience/gingerol
